Techne Corporation http://www.alacrastore.com/company-snapshot/Techne_Corporation-1032895 27 Nov 2009 08:30:05 EST 1032895 Techne Corporation en AlacraStore RSS Builder 1.0 30 http://www.alacrastore.com/storecontent/bir/211521211521bir/211521norm17Techne Corp.Medix Biotech Inc.R and D Systems Inc.United States24 Jul 2009 06:15:00 ESTManufacturing: Biological products, including hematology controls, purified proteins (cytokines) and antibodies. Finance: Holding company for boilogical products companies.NASDAQ325414I2836E5511126719TECHManufacturing: Biological products, including hematology controls, purified proteins (cytokines) and antibodies. Finance: Holding company for boilogical products companies.Company Profiles & FinancialsGale Company ProfilesUS - In April ####, the board of Techne Corp, a Minneapolis- based manufacturer of biological products, authorized the repurchase of up to USD ## mil of the company's share capital in open market or privately negotiated transactions.30 Apr 2009 10:48:09 EST878377878377878377878377Techne CorpTechne CorpTechne CorpTechne Corphttp://www.alacrastore.com/storecontent/Thomson_M%26A/Techne_Corp_intends_a_stock_buyback-2069139020sdc/20691390202069139020Copyright © 2009, Thomson Financial, All Rights ReservedNasdaqDrugsUnited StatesBiological products, except diagnostic substances2836MNMinnesotaPublicTECH2835:In vitro and in vivo diagnostic substances2836:Biological products, except diagnostic substances6719:Offices of holding companies, nec8731:Commercial physical and biological research2835:In vitro and in vivo diagnostic substances2836:Biological products, except diagnostic substances6719:Offices of holding companies, nec8731:Commercial physical and biological researchNasdaqDrugsUnited StatesBiological products, except diagnostic substances2836MNMinnesotaPublicTECH167248001Mnfr biological prodMnfr biological prodCashCash OnlyCommon Stock167248001Apr 30 200911.21700143.96100160.71700151.54600131.14800115.45800103.8710088.31300420.494000.020000.00000152.966002.82000109.06200161.78700268.491000.00000429.260000.000000.000000.000000.000000.000000.0000031 Dec 0830 Jun 0830 Jun 0730 Jun 0630 Jun 0530 Jun 041.000001.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.0000017.00000Techne Corp, headquartered inMinneapolis, Minnesota,manufactures and wholesalesbiological products throughits subsidiaries Research &Diagnostic Systems Inc and R&DSystems Europe Ltd. The formerunit manufactures hematologycontrols and developsbiotechnology productsincluding purified proteinsand antibodies as well asassay kits, while the lattersells and distributes thegroup's products in Europe.The company was founded in1981.Techne Corp, headquartered in Minneapolis, Minnesota,manufactures and wholesales biological products through itssubsidiaries Research & Diagnostic Systems Inc and R&DSystems Europe Ltd. The former unit manufactures hematologycontrols and develops biotechnology products includingpurified proteins and antibodies as well as assay kits,while the latter sells and distributes the group's productsin Europe. The company was founded in 1981.Techne Corp, headquartered in Minneapolis, Minnesota, manufactures and wholesales biological products through its subsidiaries Research & Diagnostic Systems Inc and R&D Systems Europe Ltd. The former unit manufactures hematology controls and develops biotechnology products including purified proteins and antibodies as well as assay kits, while the latter sells and distributes the group's products in Europe. The company was founded in 1981.1.000002.000003.000004.000005.000006.000007.000008.000009.0000010.0000011.0000012.0000013.0000014.0000015.0000016.0000017.00000Techne Corp, headquartered inMinneapolis, Minnesota,manufactures and wholesalesbiological products throughits subsidiaries Research &Diagnostic Systems Inc and R&DSystems Europe Ltd. The formerunit manufactures hematologycontrols and developsbiotechnology productsincluding purified proteinsand antibodies as well asassay kits, while the lattersells and distributes thegroup's products in Europe.The company was founded in1981.Techne Corp, headquartered in Minneapolis, Minnesota,manufactures and wholesales biological products through itssubsidiaries Research & Diagnostic Systems Inc and R&DSystems Europe Ltd. The former unit manufactures hematologycontrols and develops biotechnology products includingpurified proteins and antibodies as well as assay kits,while the latter sells and distributes the group's productsin Europe. The company was founded in 1981.Techne Corp, headquartered in Minneapolis, Minnesota, manufactures and wholesales biological products through its subsidiaries Research & Diagnostic Systems Inc and R&D Systems Europe Ltd. The former unit manufactures hematology controls and develops biotechnology products including purified proteins and antibodies as well as assay kits, while the latter sells and distributes the group's products in Europe. The company was founded in 1981.0.000000.000000.0000037.49000NU.S. Dollar28 Apr 09Tue, 28 Apr 2009 00:00:00 ESTDate Announced: 04/28/2009Date Effective:BuybackNot Appl.0.000000.000000.000000.000000.000000.00000Price/Share0.0000060 U.S. Dollar60.000000.0000060 U.S. Dollar60.000000.000000.000000.000000.000000.0000060 U.S. Dollar1.00000N41.020000.000000.000000.000000.000000.0000060.0000060.000000.000000.000000.000000.000000.0000019.401004.877000.000000.000000.000000.000000.000000.000000.000000.392000.000000.000000.0000014.5670014.454000.000000.0000019.4580020.074000.000002051.04700420.4940019.6360013.1270018.8200018.270001.000002.000003.000004.000005.000006.000007.000008.000009.00000US - In April 2009, the boardof Techne Corp, a Minneapolis-based manufacturer ofbiological products,authorized the repurchase ofup to USD 60 mil of thecompany's share capital inopen market or privatelynegotiated transactions.US - In April 2009, the board of Techne Corp, a Minneapolis- based manufacturer of biological products, authorized the repurchase of up to USD 60 mil of the company's share capital in open market or privately negotiated transactions.US - In April 2009, the board of Techne Corp, a Minneapolis- based manufacturer ofbiological products, authorized the repurchase of up to USD 60 mil of the company's sharecapital in open market or privately negotiated transactions.US - In April 2009, the board of Techne Corp, a Minneapolis- based manufacturer of biological products, authorized the repurchase of up to USD 60 mil of the company's share capital in open market orprivately negotiated transactions.US - In April 2009, the board of Techne Corp, a Minneapolis- based manufacturer of biological products, authorized the repurchase of upto USD 60 mil of the company's share capital in open market or privately negotiated transactions.Intended0.000000.000000.000000.0000011.21700160.71700151.54600131.14800115.45800103.8710088.31300420.49400152.966002.640002.150001.850001.620001.270002.82000420.49400487.13000437.65100340.34800267.86900297.42500103.5580085.1110073.3510066.1320052.92800109.06200154.97100129.89700111.58100100.1930082.54100161.78700257.42000223.48200202.61700178.652000.00000268.49100429.26000502.31400450.48200365.87400288.73900317.61700Status:IntendedUS-999.00000np0.60300-999.00000np17.8500017.0560025.9370012.715000.00000420.4940017.1710012.142000.000000.000000.000002835:In vitro and in vivo diagnostic substances2836:Biological products, except diagnostic substances6719:Offices of holding companies, nec8731:Commercial physical and biological research167248001NasdaqUnited States2836MinnesotaPublicTECH2835:In vitro and in vivo diagnostic substances2836:Biological products, except diagnostic substances6719:Offices of holding companies, nec8731:Commercial physical and biological research167248001NasdaqUnited States2836MinnesotaPublicTECH60.0000060.0000060.0000041.02000Deal InformationTF Mergers & Acquisitionshttp://www.alacrastore.com/storecontent/srp/2678126781srp/26781norm00008420232678187837710006 Oct 2006 12:23:00 ESTTechne_TECH_Defense_Analytics_Profile.pdfTECH...corporation within two years following the offeror's last purchase of shares in a takeover offer, unless the selling shareholder is given a reasonable opportunity to dispose of his or her shares to the offeror upon terms substantially equivalent to those provided in the takeover offer. However, the fair price provision does not apply if the acquisition is approved by a committee of the board's disinterested directors, who are not affiliated with the offeror, before the purchase of any shares by the offeror under a takeover offer. ("Fair price provision")... Credit & Investment ResearchSharkRepellent.net